STE Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 1.21%, SMA50 -0.33%, SMA200 3.26%). The stock’s 14-day RSI is 52.59 (neutral), while the ATR of 6.47 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -5.47% below its high and over 24.3% above its low. Average 10-day trading volume of 543.70 thousand shares is below the 3-month average of 727.94 thousand, indicating normal recent market interest.

STERIS plc generated EPS of $7.23 over the past year. Five-year average earnings growth is 5.92%. Wall Street analysts project EPS growth of 9.62% annually over the next five years. The latest quarter delivered EPS of $2.59. The next quarter is forecast at $2.85. Next year's EPS is expected at $9.85. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $275.00 to $269.00. The high target offers 25.89% upside. The low target suggests 23.15% downside. The mean target is $272.00. This offers 24.52% upside. STERIS plc earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 05, 2026, missed forecasts by 4.02%. The prior quarter beat by -1.05%. Over the last six quarters, Apple has recorded several small beats. These include 5.38% in May 14, 2025.

STERIS plc last paid a dividend of 2.58 per share, this equals a trailing yield of roughly 0.87%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $380.77. This means the shares are trading below this model’s fair value.

STERIS plc has 97.50 million shares outstanding. The public float is 97.08 million shares, elevated short interest at 3.25% of float. This equals 3.16 million shares. The short ratio is 4.34 days. Institutional investors hold 101.36% of the float. Insiders own 0.31%. Carestio Daniel A holds 63.65 thousand shares, Rosebrough Walter M Jr has 51.40 thousand shares and TOKICH MICHAEL J has 42.93 thousand shares. Over the past six months, insider transactions show net selling. They sold 11.39 thousand shares across 5 transactions.

STERIS plc (NYSE:STE) shares are flat 1.76% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows STERIS plc trading at a premium to the broader market with a P/E of 26.76. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $220.57, suggesting 0.98% upside. Our AI forecast model points to short-term strength (0.57% over two weeks), a medium-term rise (23.33% over three months), and a longer-term gain (7.99% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that STERIS plc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.57%, with price expected at $219.69 by September 18, 2026, within a range of $215.19 to $224.53 3-Month Outlook: Projected rise of 23.33%, reaching $269.41 by December 03, 2026, with a range of $264.80 to $273.51. 1-Year Outlook: Projected gain of 7.99%, with price at $235.90 by September 03, 2027, within a range of $229.65 to $239.72.

STERIS plc (NYSE:STE) closed at $218.44 USD, losing -$6.15 (-2.74%) from the previous close of $224.59. The stock is currently mid-range between its 52-week high and low $195.14 and $269.44. With a market capitalization of about $21.29 billion, STERIS plc is classified as a large-cap and shows market-like volatility (beta ~0.91). Key stats such as the average daily volume over the past year has been around 745.26 thousand shares, in line with its 52-week average. Headquartered in Mentor, OH, STERIS plc operates in the Healthcare sector and the Medical - Specialties industry. Led by CEO Daniel A. Carestio, the company employs approximately 17,937 people and listed since June 01, 1992. STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.

STERIS plc trades at a P/E ratio of 26.76, slightly below the S&P 500 average, with a price-to-sales ratio of 3.54 and a price-to-book ratio of 2.97 suggesting the stock is closer to book value. The P/FCF stands at 23.1, also above market averages.